BGI Genomics Co., Ltd. 300676.SZ Stock
BGI Genomics Co., Ltd. Price Chart
BGI Genomics Co., Ltd. 300676.SZ Financial and Trading Overview
| BGI Genomics Co., Ltd. stock price | 38.96 CNY |
| Previous Close | 57.73 CNY |
| Open | 57.8 CNY |
| Bid | 58.32 CNY x 0 |
| Ask | 58.34 CNY x 0 |
| Day's Range | 57.46 - 58.49 CNY |
| 52 Week Range | 50.91 - 79.85 CNY |
| Volume | 2.84M CNY |
| Avg. Volume | 7.54M CNY |
| Market Cap | 24.14B CNY |
| Beta (5Y Monthly) | 0.584931 |
| PE Ratio (TTM) | 46.656 |
| EPS (TTM) | 0.3 CNY |
| Forward Dividend & Yield | 1 (1.73%) |
| Ex-Dividend Date | June 7, 2023 |
| 1y Target Est | N/A |
300676.SZ Valuation Measures
| Enterprise Value | 20.21B CNY |
| Trailing P/E | 46.656 |
| Forward P/E | 22.090908 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.6743371 |
| Price/Book (mrq) | 2.625726 |
| Enterprise Value/Revenue | 3.075 |
| Enterprise Value/EBITDA | 24.39 |
Trading Information
BGI Genomics Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.584931 |
| 52-Week Change | -15.16% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 79.85 CNY |
| 52 Week Low | 50.91 CNY |
| 50-Day Moving Average | 63.13 CNY |
| 200-Day Moving Average | 58.6 CNY |
300676.SZ Share Statistics
| Avg. Volume (3 month) | 7.54M CNY |
| Avg. Daily Volume (10-Days) | 2.87M CNY |
| Shares Outstanding | 413.91M |
| Float | 237.02M |
| Short Ratio | N/A |
| % Held by Insiders | 46.86% |
| % Held by Institutions | 8.84% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 1.73% |
| 5 Year Average Dividend Yield | 40.00% |
| Payout Ratio | 0.2816 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 7.82% |
| Operating Margin (ttm) | 7.09% |
| Gross Margin | 47.50% |
| EBITDA Margin | 12.60% |
Management Effectiveness
| Return on Assets (ttm) | 2.15% |
| Return on Equity (ttm) | 5.28% |
Income Statement
| Revenue (ttm) | 6.57B CNY |
| Revenue Per Share (ttm) | 15.6 CNY |
| Quarterly Revenue Growth (yoy) | -33.30% |
| Gross Profit (ttm) | 7.13B CNY |
| EBITDA | 828.4M CNY |
| Net Income Avi to Common (ttm) | 513.86M CNY |
| Diluted EPS (ttm) | 1.25 |
| Quarterly Earnings Growth (yoy) | -87.50% |
Balance Sheet
| Total Cash (mrq) | 6.26B CNY |
| Total Cash Per Share (mrq) | 13.8 CNY |
| Total Debt (mrq) | 121.11M CNY |
| Total Debt/Equity (mrq) | 1.18 CNY |
| Current Ratio (mrq) | 2.729 |
| Book Value Per Share (mrq) | 22.211 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 833.83M CNY |
| Levered Free Cash Flow (ttm) | 268.29M CNY |
Profile of BGI Genomics Co., Ltd.
| Country | China |
| State | N/A |
| City | Shenzhen |
| Address | Building No.7 |
| ZIP | 518083 |
| Phone | 86 755 2527 3120 |
| Website | https://www.bgi.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 4448 |
BGI Genomics Co., Ltd. provides sequencing services and a portfolio of genetic tests for medical institutions, research institutions, and other public and private partners in China and internationally. The company offers DNA, RNA, and customized sequencing services; and non-invasive prenatal testing, reproductive health screening, newborn genetic screening, and clinical exome sequencing services, as well as clinical and research solutions for oncology. It also offers laboratory solutions for the detection and diagnosis of patients suspected with COVID-19; SARS-CoV-2 IgM and IgG antibody detection kit; and real-time fluorescent RT-PCR kit for detecting SARS-CoV-2. The company offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015. BGI Genomics Co., Ltd. was founded in 1999 and is headquartered in Shenzhen, China.
Q&A For BGI Genomics Co., Ltd. Stock
What is a current 300676.SZ stock price?
BGI Genomics Co., Ltd. 300676.SZ stock price today per share is 38.96 CNY.
How to purchase BGI Genomics Co., Ltd. stock?
You can buy 300676.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BGI Genomics Co., Ltd.?
The stock symbol or ticker of BGI Genomics Co., Ltd. is 300676.SZ.
Which industry does the BGI Genomics Co., Ltd. company belong to?
The BGI Genomics Co., Ltd. industry is Diagnostics & Research.
How many shares does BGI Genomics Co., Ltd. have in circulation?
The max supply of BGI Genomics Co., Ltd. shares is 413.91M.
What is BGI Genomics Co., Ltd. Price to Earnings Ratio (PE Ratio)?
BGI Genomics Co., Ltd. PE Ratio is 129.86665000 now.
What was BGI Genomics Co., Ltd. earnings per share over the trailing 12 months (TTM)?
BGI Genomics Co., Ltd. EPS is 0.3 CNY over the trailing 12 months.
Which sector does the BGI Genomics Co., Ltd. company belong to?
The BGI Genomics Co., Ltd. sector is Healthcare.